Beta Bionics (BBNX) | Stock Overview & Key Data
Beta Bionics Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $32.71 on November 26, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Beta Bionics
BBNX
|
497.75M Small-cap | 7.05% | 21.82% | 7.61% | -59.05% | -57.44% | -29.70% | -49.10% | -49.10% | -49.10% | -49.10% | -49.10% |
| 160.70B Large-cap | 1.53% | -0.63% | -23.43% | -30.57% | -29.95% | -35.92% | -17.85% | -21.68% | 118.48% | 249.25% | 313.73% | |
|
Stryker
SYK
|
126.25B Large-cap | -3.58% | 1.42% | -23.29% | -19.39% | -15.27% | -20.27% | 9.63% | 21.15% | 168.66% | 406.79% | 583.29% |
|
Axogen
AXGN
|
1.94B Small-cap | 1.91% | -4.69% | 36.21% | 43.42% | 31.06% | 262.53% | 346.61% | 108.01% | 590.21% | 1,114.77% | 9,770.00% |
|
Establishment Labs
ESTA
|
1.91B Small-cap | 1.53% | 3.09% | 1.83% | 6.86% | 5.19% | 105.37% | 6.40% | -6.53% | 167.87% | 167.87% | 167.87% |
|
Artivion
AORT
|
1.83B Small-cap | -9.58% | -42.08% | -46.71% | -54.75% | -53.71% | -24.98% | 45.13% | -23.19% | 88.21% | 317.89% | 366.18% |
Ownership & Short Interest
Calculate Your Beta Bionics Investment Returns
Long-Term Investment Performance Analysis
Beta Bionics stock price in Jan 2025 was $23.81, A $1,000.00 lump sum investment in Beta Bionics made 1 years ago would be worth approximately $522.89 today, representing a negative return of -47.71%. This translates to an annualized return (CAGR) of -38.20%.
1 Year 4 Months Investment Scenario (Jan 2025 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BBNX's 52-week high and low?
- In the last 52 weeks, Beta Bionics reached a high of $32.71 (on November 26, 2025) and a low of $8.80 (on April 10, 2026).
- What is the market cap and P/E ratio for BBNX?
- Curious about Beta Bionics's size and valuation? Its market capitalization stands at 497.75M. When it comes to valuation, the P/E ratio (trailing twelve months) is -6.17, and the forward P/E (looking ahead) is -5.67.
- Does BBNX pay dividends? If so, what's the yield?
- As for dividends, Beta Bionics isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Beta Bionics's main competitors or similar companies to consider before investing?
When looking at Beta Bionics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -35.92% -17.85% Stryker
SYK126.25B Healthcare Medical Devices -20.27% 9.63% Axogen
AXGN1.94B Healthcare Medical Devices 262.53% 346.61% Establishment Labs
ESTA1.91B Healthcare Medical Devices 105.37% 6.40% Artivion
AORT1.83B Healthcare Medical Devices -24.98% 45.13% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Beta Bionics Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Beta Bionics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -22.71%, the Debt to Equity ratio from the most recent quarter is 2.55, and its Gross Profit Margin stands at 59.50%.
- What is the recent revenue and earnings growth for BBNX?
- Looking at Beta Bionics's growth, its revenue over the trailing twelve months (TTM) was $110M. Compared to the same quarter last year (YoY), quarterly revenue grew by 56.60%, and quarterly earnings saw a YoY growth of 56.62%.
- How much of BBNX stock is held by insiders and institutions?
- Wondering who owns Beta Bionics stock? Company insiders (like executives and directors) hold about 0.97% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 109.48%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.